Rays Of Hope Intervention Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 950 N Main St Ste 2, Monticello, KY 42633 Phone: 606-307-6688 Fax: 606-396-8006 |
Cardinal Community Mental Health Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 250 N Main St, Monticello, KY 42633 Phone: 606-278-6751 |
N/a Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 179 W Evelyn Ave, Monticello, KY 42633 Phone: 606-875-2924 |
True To You Counseling Service Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 126 E Evelyn Ave, Monticello, KY 42633 Phone: 859-212-6806 Fax: 606-348-0440 |
Rise Mental Health And Wellness Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1215 N Main St Ste 1, Monticello, KY 42633 Phone: 606-575-0003 |
News Archive
With Obama administration officials part of the campaign against the Ryan plan, other opponents also are stepping forward and launching a new wave of television ads in Wisconsin Republican Rep. Paul Ryan's very own congressional district. Meanwhile, The Washington Post analyzes some of the poll numbers behind where voters may stand on Medicare cuts.
In 2011, more Danes became infected with MRSA bacteria, and the number was the highest in over 25 years. The increase was primarily seen in otherwise healthy people without any hospital relation. Although the number of MRSA positive pig herds is on a par with the level seen in 2010, significantly more pigs at slaughter were found to be infected with the so-called pig MRSA, and the number of people infected with pig MRSA is increasing. This appears from the Danish surveillance report, DANMAP, for 2011.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced data which support the safety and efficacy of the EndoBarrierâ„¢ Gastrointestinal Liner for pre-surgical weight loss treatment, along with a positive effect on glucose homeostasis in morbidly obese patients with type 2 diabetes mellitus.
A new trial involving the use of an antibody called anifrolumab reports improvement in patients with systemic lupus erythematosus (SLE) after 52 weeks of treatment. The research, titled 'Trial of Anifrolumab in Active Systemic Lupus Erythematosus', is published in the New England Journal of Medicine.
› Verified 4 days ago